EUR RADIOL 2021 10.1007/s00330-021-08094-3

Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer

Cha¹, DI; Lee, J; Jeong, WK; Kim, ST; Kim, JH; Hong, JY; Kang, WK; Kim, KM; Kim, SW; Choi, D

AM J SURG PATHOL 2021 10.1097/PAS.0000000000001651

Gastric Inverted Polyps-Distinctive Subepithelial Lesions of the Stomach Clinicopathologic Analysis of 12 Cases With an Emphasis on Neoplastic Potential

Kim¹, JY; Ahn, S; Kim, KM; Chang, SH; Kim, HS; Lee, JH; Kim, JJ; Sohn, TS; Kang, HJ; Joo, M

MODERN PATHOL 2021 10.1038/s41379-021-00823-9

PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy

Ahn¹, S; Kim, KM

CANCERS 2021 10.3390/cancers13102316

Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer

Kim¹, JC; Heo, YJ; Kang, SY; Lee, J; Kim, KM

J CANCER RES CLIN 2021 10.1007/s00432-021-03581-y

Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer

Na¹, JE; Lee, H; Min, YW; Min, BH; Lee, JH; Rhee, PL; Kim, KM; Kim, JJ

ANN ONCOL 2021 10.1016/j.annonc.2020.11.017

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

Park¹, SH; Lim, DH; Sohn, TS; Lee, J; Zang, DY; Kim, ST; Kang, JH; Oh, SY; Hwang, IG; Ji, JH; Shin, DB; Yu, JI; Kim, KM; An, JY; Choi, MG; Lee, JH; Kim, S; Hong, JY; Park, JO; Park, YS; Lim, HY; Bae, JM; Kang, WK

GASTRIC CANCER 2021 10.1007/s10120-021-01170-z

Identification of anti-epstein-barr virus (EBV) antibody signature in EBV-associated gastric carcinoma

Song¹, LS; Song, M; Camargo, MC; Van Duine, J; Williams, S; Chung, Y; Kim, KM; Lissowska, J; Sivins, A; Gao, WM; Karthikeyan, K; Park, J; Leja, M; Cohen, JI; LaBaer, J; Qiu, J; Rabkin, CS

THER ADV MED ONCOL 2021 10.1177/1758835921992992

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors

Kim¹, H; Hong, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Kim, ST

PATHOL RES PRACT 2021 10.1016/j.prp.2020.153338

PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study

Heo¹, YJ; Kim, B; Kim, H; Kim, S; Jang, MS; Kim, KM

HISTOPATHOLOGY 2021 10.1111/his.14294

Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum

Pereira¹, D; Kovari, B; Brown, I; Chaves, P; Choi, WT; Clauditz, T; Ghayouri, M; Jiang, K; Miller, GC; Nakanishi, Y; Kim, KM; Kim, BH; Kumarasinghe, MP; Kushima, R; Ushiku, T; Yozu, M; Srivastava, A; Goldblum, JR; Pai, RK; Lauwers, GY

GENOME MED 2021 10.1186/s13073-021-00826-w

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

Kim¹, ST; Sa, JK; Oh, SY; Kim, K; Hong, JY; Kang, WK; Kim, KM; Lee, J

J IMMUNOL 2020 10.4049/jimmunol.1901470

IL-7R alpha(low) CD8(+) T Cells from Healthy Individuals Are Anergic with Defective Glycolysis

Sim¹, JH; Kim, JH; Park, AK; Lee, J; Kim, KM; Shin, HM; Kim, M; Choi, K; Choi, EY; Kang, I; Lee, DS; Kim, HR

RADIOTHER ONCOL 2020 10.1016/j.radonc.2020.07.043

Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer Analysis of the ARTIST phase III trial

Yu¹, JI; Choi, C; Lee, J; Kang, WK; Park, SH; Kim, ST; Hong, JY; Kim, S; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, KM; Han, H; Kim, K; Nam, H; Lim, DH

CANCER RES TREAT 2020 10.4143/crt.2020.173

A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer

An¹, JY; Choi, YY; Lee, J; Hyung, WJ; Kim, KM; Noh, SH; Choi, MG; Cheong, JH

MODERN PATHOL 2020 10.1038/s41379-020-00681-x

MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer

Kim¹, S; Bae, WJ; Ahn, JM; Heo, JH; Kim, KM; Choi, KW; Sung, CO; Lee, D

J PATHOL CLIN RES 2020 10.1002/cjp2.179

Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis a direct comparison study in 153 gastric carcinomas

Heo¹, YJ; Lee, T; Byeon, SJ; Kim, EJ; Shin, HC; Kim, B; Kang, SY; Ha, SY; Kim, KM

GASTRIC CANCER 2020 10.1007/s10120-020-01124-x

Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors

Kim¹, YY; Lee, J; Jeong, WK; Kim, ST; Kim, JH; Hong, JY; Kang, WK; Kim, KM; Sohn, I; Choi, D

CANCERS 2020 10.3390/cancers12071724

PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression

Kim¹, B; Kang, SY; Kim, D; Heo, YJ; Kim, KM

THER ADV MED ONCOL 2020 10.1177/1758835920926796

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients

Kim¹, ST; Hong, JY; Park, SH; Park, JO; Park, YW; Park, N; Lee, H; Hong, SH; Lee, SJ; Song, SW; Kim, K; Park, YS; Lim, HY; Kang, WK; Nam, H; Lee, JW; Park, K; Kim, KM; Lee, J

PATHOL RES PRACT 2020 10.1016/j.prp.2020.152941

CDH1 mutations in gastric cancers are not associated with family history

Choi¹, S; Jang, J; Heo, YJ; Kang, SY; Kim, ST; Lee, J; Kang, WK; Kim, JW; Kim, KM

Transl Cancer Res 2020 10.21037/tcr-19-1876

Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer

Hong¹, JY; An, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kim, KM; Kang, WK; Kim, ST

J CLIN MED 2020 10.3390/jcm9041064

Favorable Long-Term Outcomes of Endoscopic Submucosal Dissection for Differentiated-Type-Predominant Early Gastric Cancer with Histological Heterogeneity

Kim¹, TS; Shin, HC; Min, BH; Kim, KM; Min, YW; Lee, H; Lee, JH; Rhee, PL; Kim, JJ

PATHOL RES PRACT 2020 10.1016/j.prp.2020.152881

High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features

Liu¹, XQ; Choi, MG; Kim, K; Kim, KM; Kim, ST; Park, SH; Cristescu, R; Peter, S; Lee, J

PATHOL RES PRACT 2020 10.1016/j.prp.2020.152878

High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers

Hur¹, JY; Chao, J; Kim, K; Kim, ST; Kim, KM; Klempner, SJ; Lee, J

SCI REP-UK 2020 10.1038/s41598-020-63230-1

Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa

Kim¹, B; Jang, J; Heo, YJ; Kang, SY; Yoo, H; Sohn, I; Min, BH; Kim, KM

CANCERS 2020 10.3390/cancers12040943

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer

Yu¹, JI; Park, HC; Lee, J; Choi, C; Kang, WK; Park, SH; Kim, ST; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, KM; Han, H; Kim, K; Kim, S; Lim, DH

Front Oncol 2020 10.3389/fonc.2020.00314

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Kim¹, J; Kim, B; Kang, SY; Heo, YJ; Park, SH; Kim, ST; Kang, WK; Lee, J; Kim, KM

PATHOL RES PRACT 2020 10.1016/j.prp.2020.152820

TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer

Hong¹, JY; Kim, HJ; Kim, K; Hong, J; Kim, JE; Byeon, SJ; Lee, IK; Kim, KM; Shim, M; Park, SH; Park, JO; Park, YS; Lim, HY; Kim, ST; Lee, J; Kang, WK

VIRCHOWS ARCH 2020 10.1007/s00428-019-02653-2

PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation

Kim¹, HN; Jang, J; Heo, YJ; Kim, B; Jung, HR; Jang, Y; Kang, SY; Kim, ST; Lee, JY; Kang, WK; Kim, KM

Front Oncol 2020 10.3389/fonc.2020.00225

A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling

Chao¹, JS; Lee, J; Kim, K; Kang, SY; Lee, T; Kim, KM; Kim, ST; Klempner, SJ; Lee, H

CANCER EPIDEM BIOMAR 2020 10.1158/1055-9965.EPI-19-0790

Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer

Camargo¹, MC; Kim, KM; Matsuo, K; Torres, J; Liao, LM; Morgan, D; Michel, A; Waterboer, T; Song, M; Gulley, ML; Dominguez, RL; Yatabe, Y; Kim, S; Cortes-Martinez, G; Lissowska, J; Zabaleta, J; Pawlita, M; Rabkin, CS

Genome Med 2020 10.1186/s13073-020-0717-8

Comprehensive pharmacogenomic characterization of gastric cancer

Sa¹, JK; Hong, JY; Lee, IK; Kim, JS; Sim, MH; Kim, HJ; An, JY; Sohn, TS; Lee, JH; Bae, JM; Kim, S; Kim, KM; Kim, ST; Park, SH; Park, JO; Lim, HY; Kang, WK; Her, NG; Lee, Y; Cho, HJ; Shin, YJ; Kim, M; Koo, H; Kim, M; Seo, YJ; Kim, JY; Choi, MG; Nam, DH; Lee, J

EJSO-EUR J SURG ONC 2020 10.1016/j.ejso.2019.08.025

Prognostic value of mismatch repair deficiency in patients with advanced gastric cancer, treated by surgery and adjuvant 5-fluorouracil and leucovorin chemoradiotherapy

Kim¹, SM; An, JY; Byeon, SJ; Lee, J; Kim, KM; Choi, MG; Lee, JH; Sohn, TS; Moon, J; Kim, S

PATHOL RES PRACT 2020 10.1016/j.prp.2019.152734

Correlation between RICTOR overexpression and amplification in advanced solid tumors

Bang¹, H; Ahn, S; Kim, EJ; Kim, ST; Park, H; Lee, J; Kim, KM

J ONCOL 2020 10.1155/2020/4659062

Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers

Lee¹, SJ; Hong, JY; Kim, K; Kim, KM; Kang, SY; Lee, T; Kim, ST; Park, SH; Park, YS; Lim, HY; Kang, WK; Lee, J; Park, JO

CLIN CANCER RES 2019 10.1158/1078-0432.CCR-19-1324

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel

Willis¹, J; Lefterova, MI; Artyomenko, A; Kasi, PM; Nakamura, Y; Mody, K; Catenacci, DVT; Fakih, M; Barbacioru, C; Zhao, J; Sikora, M; Fairclough, SR; Lee, H; Kim, KM; Kim, ST; Kim, J; Gavino, D; Benavides, M; Peled, N; Nguyen, T; Cusnir, M; Eskander, RN; Azzi, G; Yoshino, T; Banks, KC; Raymond, VM; Lanman, RB; Chudova, DI; Talasaz, A; Kopetz, S; Lee, J; Odegaard, JI

TRANSL ONCOL 2019 10.1016/j.tranon.2019.07.017

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study

Kwon¹, D; Kim, B; Shin, HC; Kim, EJ; Ha, SY; Jang, KT; Kim, ST; Lee, J; Kang, WK; Park, JO; Kim, KM

INT J CANCER 2019 10.1002/ijc.32228

Bridging genomics and phenomics of gastric carcinoma

Cho¹, J; Ahn, S; Son, DS; Kim, NKD; Lee, KW; Kim, S; Lee, J; Park, SH; Park, JO; Kang, WK; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, KM

J IMMUNOTHER 2019 10.1097/CJI.0000000000000283

LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target

Lee¹, SJ; Byeon, SJ; Lee, J; Park, SH; Park, JO; Park, YS; Kang, WK; Lim, HY; Kim, KM; Kim, ST

CANCER RES TREAT 2019 10.4143/crt.2019.019

Inter-observer Reproducibility in the Pathologic Diagnosis of Gastric Intraepithelial Neoplasia and Early Carcinoma in Endoscopic Submucosal Dissection Specimens: A Multi-center Study

Kim¹, OM; Sohn, JH; Cho, MY; Kim, WH; Chang, HK; Jung, ES; Kook, MC; Jin, SY; Chae, YS; Park, YS; Kang, MS; Kim, H; Lee, JH; Park, D; Kim, KM; Kim, H; Suh, YJ; Seol, SY; Jung, HY; Kim, DH; Lee, NR; Park, SH; You, JH

CANCER DISCOV 2019 10.1158/2159-8290.CD-19-0442

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

Lee¹, J; Kim, ST; Kim, K; Lee, H; Kozarewa, I; Mortimer, PGS; Odegaard, JI; Harrington, EA; Lee, J; Lee, T; Oh, SY; Kang, JH; Kim, JH; Kim, Y; Ji, JH; Kim, YS; Lee, KE; Kim, J; Sohn, TS; An, JY; Choi, MG; Lee, JH; Bae, JM; Kim, S; Kim, JJ; Min, YW; Min, BH; Kim, NKD; Luke, S; Kim, YH; Hong, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Talasaz, A; Hollingsworth, SJ; Kim, KM; Kang, WK

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152525

Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum

Kwon¹, MJ; Byeon, S; Kang, SY; Kim, KM

PATHOLOGY 2019 10.1016/j.pathol.2019.01.013

Gastrointestinal stromal tumour with CDKN2A deletions: a report of three cases

Kim¹, B; Ha, SY; Lee, S; Kim, KM

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152434

CCNE1 amplification is associated with liver metastasis in gastric carcinoma

Kim¹, B; Shin, HC; Heo, YJ; Ha, SY; Jang, KT; Kim, ST; Kang, WK; Lee, J; Kim, KM

SCI REP-UK 2019 10.1038/s41598-019-46216-6

Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue

Heo¹, YJ; Park, C; DoyeongYu; Lee, J; Kim, KM

J MOL DIAGN 2019 10.1016/j.jmoldx.2019.02.007

Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing A Direct Comparison Study with Immunohistochemistry

Choi¹, S; Chu, J; Kim, B; Ha, SY; Kim, ST; Lee, J; Kang, WK; Han, H; Sohn, I; Kim, KM

Am J Transl Res 2019

Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification

Kim¹, ST; Lee, IK; Rom, E; Sirkis, R; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Yayon, A; Lee, J

J GASTROEN HEPATOL 2019 10.1111/jgh.14756

Outcomes of endoscopic submucosal dissection for intestinal-type adenocarcinoma with anastomosing glands of the stomach

Kim¹, TS; Kim, B; Min, BN; Min, YW; Lee, H; Lee, JH; Rhee, PL; Kim, JJ; Kushima, R; Kim, KM

J Cancer 2019 10.7150/jca.30257

High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer

Kim¹, Y; Byeon, SJ; Hur, J; Lee, K; Kim, D; Ahn, JH; Lee, SH; You, WK; Kim, ST; Park, SH; Kang, WK; Kim, KM; Lee, J

ONCOLOGY-BASEL 2019 10.1159/000499628

Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial

Miceli¹, R; An, J; Di Bartolomeo, M; Morano, F; Kim, ST; Park, SH; Choi, MG; Lee, JH; Raimondi, A; Fuca, G; Sohn, TS; Bae, JM; Kim, S; Lim, DH; Kang, WK; Kim, KM; Pietrantonio, F; Lee, J

Front Oncol 2019 10.3389/fonc.2019.00212

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort

Lee¹, J; Franovic, A; Shiotsu, Y; Kim, ST; Kim, KM; Banks, KC; Raymond, VM; Lanman, RB

SURGERY 2019 10.1016/j.surg.2018.11.001

Effect of age on the clinical outcomes of patients with early gastric cancer with undifferentiated-type histology

Pyo¹, JH; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Yoo, H; Kim, K; Choi, YH; Kim, JJ; Kim, S

TRANSL ONCOL 2019 10.1016/j.tranon.2018.12.009

Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial

Kim¹, ST; Lee, S; Park, M; Park, SH; Park, JO; Lim, HY; Park, YS; Kang, WK; Gangolli, EA; Shin, H; Kim, KM; Hollingsworth, SJ; Mortimer, PGS; Lee, J

GASTRIC CANCER 2019 10.1007/s10120-018-0857-3

Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection

Kim¹, TS; Min, BH; Kim, KM; Lee, JH; Rhee, PL; Kim, JJ

ANN ONCOL 2019 10.1093/annonc/mdy550

Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

Sundar¹, R; Huang, KK; Qamra, A; Kim, KM; Kim, ST; Kang, WK; Tan, ALK; Lee, J; Tan, P

PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.010

MET is overexpressed in microsatellite instability-high gastric carcinoma

Sim¹, J; Heo, YJ; Bae, H; Shin, HC; Kim, B; Cho, J; Kim, ST; Lee, J; Kang, WK; Kim, KM

Oncoimmunology 2019 10.1080/2162402X.2018.1544442

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer

Angell¹, HK; Lee, J; Kim, KM; Kim, K; Kim, ST; Park, SH; Kang, WK; Sharpe, A; Ogden, J; Davenport, A; Hodgson, DR; Barrett, JC; Kilgour, E

ANN SURG ONCOL 2019 10.1245/s10434-018-07119-4

Feasibility of Endoscopic Resection in Early Gastric Cancer with Lymphovascular Invasion

Pyo¹, JH; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Kim, H; Kim, K; Kim, JJ

PATHOL RES PRACT 2019 10.1016/j.prp.2018.10.024

The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma

Cho¹, J; Kim, KM; Kim, HC; Lee, WY; Kang, WK; Park, YS; Ha, SY

PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.013

Pathologic analyses of peritoneal nodules in gastric cancer patients during surgery-A single cancer center experience with diagnostic pitfalls

Bae¹, H; Kim, H; Chu, J; Jang, Y; Koh, HH; Jung, H; Ha, SY; Jang, KT; Kim, KM

PATHOLOGY 2019 10.1016/j.pathol.2018.09.057

MMR protein immunohistochemistry and microsatellite instability in gastric cancers

Cho¹, J; Kang, SY; Kim, KM

Oncotarget. 2018 Feb 9;9(16):12591-12598. doi: 10.18632/oncotarget.24476. eCollection 2018 Feb 27.

Peritumoral lymphoid cuff correlates well with lymph node

Bae H#1¹, Van Vrancken M#2, Kang TW3, Park HY4, Chu J1, Park HK1, Ha SY1, Choi D3, Kim KM1.

Pathology. 2018 Nov 26. pii: S0031-3025(18)30359-3. doi: 10.1016/j.pathol.2018.09.057. [Epub ahead of print]

MMR protein immunohistochemistry and microsatellite instability in gastric cancers.

Cho J1¹, Kang SY1, Kim KM2.

J Gastric Cancer 2018 10.5230/jgc.2018.18.e34

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial

Kim¹, Y; Kim, KM; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Lee, SJ; Kim, ST; Lee, J; Park, JO; Park, YS; Lim, HY; Kang, WK; Park, SH

GASTRIC CANCER 2018 10.1007/s10120-018-0851-9

Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes

Sundar¹, R; Qamra, A; Tan, ALK; Zhang, SL; Ng, CCY; Teh, BT; Lee, J; Kim, KM; Tan, P

ANN SURG ONCOL 2018 10.1245/s10434-018-6731-z

Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study

Byeon¹, SJ; Heo, YJ; Cho, J; An, JY; Choi, MG; Lee, JH; Bae, JM; Kim, MJ; Sohn, I; Kim, S; Kim, KM; Sohn, TS

CLIN CHEM 2018 10.1373/clinchem.2018.290569

Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer

Li¹, F; Yoshizawa, JM; Kim, KM; Kanjanapangka, J; Grogan, TR; Wang, XY; Elashoff, DE; Ishikawa, S; Chia, D; Liao, W; Akin, D; Yan, XM; Lee, MS; Choi, R; Kim, SM; Kang, SY; Bae, JM; Sohn, TS; Lee, JH; Choi, MG; Min, BH; Lee, JH; Kim, JJ; Kim, Y; Kim, S; Wong, DTW

BRIT J SURG 2018 10.1002/bjs.10901

Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours

Min¹, BH; Hong, M; Lee, JH; Rhee, PL; Sohn, TS; Kim, S; Kim, KM; Kim, JJ

NAT GENET 2018 10.1038/s41588-018-0209-6

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Lee¹, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH

Front Immunol 2018 10.3389/fimmu.2018.02012

Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers

Egg¹, D; Schwab, C; Gabrysch, A; Arkwright, PD; Cheesman, E; Giulino-Roth, L; Neth, O; Snapper, S; Okada, S; Moutschen, M; Delvenne, P; Pecher, AC; Wolff, D; Kim, YJ; Seneviratne, S; Kim, KM; Kang, JM; Ojaimi, S; McLean, C; Warnatz, K; Seidl, M; Grimbacher, B

SCI REP-UK 2018 10.1038/s41598-018-32782-8

MicroRNA Expression Profiles in Gastric Carcinogenesis

Hwang¹, J; Min, BH; Jang, J; Kang, SY; Bae, H; Jang, SS; Kim, JI; Kim, KM

SCI REP-UK 2018 10.1038/s41598-018-32299-0

Computational measurement of tumor immune microenvironment in gastric adenocarcinomas

Chang¹, YH; Heo, YJ; Cho, J; Song, SY; Lee, J; Kim, KM

NAT MED 2018 10.1038/s41591-018-0101-z

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Kim¹, ST; Cristescu, R; Bass, AJ; Kim, KM; Odegaard, JI; Kim, K; Liu, XQ; Sher, XW; Jung, H; Lee, M; Lee, S; Park, SH; Park, JO; Park, YS; Lim, HY; Lee, H; Choi, M; Talasaz, A; Kang, PS; Cheng, J; Loboda, A; Lee, J; Kang, WK

ANN SURG ONCOL 2018 10.1245/s10434-018-6659-3

Young Age and Risk of Lymph Node Metastasis in Differentiated Type Early Gastric Cancer

Pyo¹, JH; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Yoo, H; Kim, K; Choi, YH; Kim, JJ; Kim, S

NAT GENET 2018 10.1038/s41588-018-0138-4

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

Alvarez¹, MJ; Subramaniam, PS; Tang, LH; Grunn, A; Aburi, M; Rieckhof, G; Komissarova, EV; Hagan, EA; Bodei, L; Clemons, PA; Dela Cruz, FS; Dhall, D; Diolaiti, D; Fraker, DA; Ghavami, A; Kaemmerer, D; Karan, C; Kidd, M; Kim, KM; Kim, HC; Kunju, LP; Langel, U; Li, Z; Lee, J; Li, H; LiVolsi, V; Pfragner, R; Rainey, AR; Realubit, RB; Remotti, H; Regberg, J; Roses, R; Rustgi, A; Sepulveda, AR; Serra, S; Shi, CJ; Yuan, XP; Barberis, M; Bergamaschi, R; Chinnaiyan, AM; Detre, T; Ezzat, S; Frilling, A; Hommann, M; Jaeger, D; Kim, MK; Knudsen, BS; Kung, AL; Leahy, E; Metz, DC; Milsom, JW; Park, YS; Reidy-Lagunes, D; Schreiber, S; Washington, K; Wiedenmann, B; Modlin, I; Califano, A

CLIN CHEM 2018 10.1373/clinchem.2017.285072

Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing

Li¹, F; Kaczor-Urbanowicz, KE; Sun, J; Majem, B; Lo, HC; Kim, Y; Koyano, K; Rao, SL; Kang, SY; Kim, SM; Kim, KM; Kim, S; Chia, D; Elashoff, D; Grogan, TR; Xiao, XS; Wong, DTW

J Cancer 2018 10.7150/jca.26256

NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines

Kim¹, SY; Oh, SO; Kim, K; Lee, J; Kang, S; Kim, KM; Lee, W; Kim, ST; Nam, DN

GASTRIC CANCER 2018 10.1007/s10120-017-0785-7

Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection

Min¹, BH; Byeon, SJ; Lee, JH; Kim, KM; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S

GASTRIC CANCER 2018 10.1007/s10120-017-0789-3

Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer

Pyo¹, JH; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Yoo, H; Ahn, S; Kim, JJ

CLIN COLORECTAL CANC 2018 10.1016/j.clcc.2018.01.005

Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer

Lee¹, J; Kim, ST; Park, S; Lee, S; Park, SH; Park, JO; Lim, HY; Ahn, H; Bok, H; Kim, KM; Ahn, MJ; Kang, WK; Park, YS

GUT LIVER 2018 10.5009/gnl17247

Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated-Type Histology: A Clinical Simulation Using a Non-Selected Surgical Cohort

Kwak¹, DS; Min, YW; Lee, JH; Kang, SH; Jang, SH; Lee, H; Min, BH; Kim, JJ; Kim, KM; Sohn, TS; Kim, S

J GASTROEN HEPATOL 2018 10.1111/jgh.14035

Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis

Pyo¹, JH; Ha, SY; Hong, SN; Chang, DK; Son, HJ; Kim, KM; Kim, H; Kim, K; Kim, JE; Choi, YH; Kim, YH

MOL CANCER THER 2018 10.1158/1535-7163.MCT-17-0535

MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis

Kim¹, HK; Lee, I; Bang, H; Kim, HC; Lee, WY; Yun, SH; Lee, J; Lee, SJ; Park, YS; Kim, KM; Kang, WK

ANN ONCOL 2018 10.1093/annonc/mdy034

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+gastric cancer patients

Kim¹, ST; Banks, KC; Pectasides, F; Kim, SY; Kim, K; Lanman, RB; Talasaz, A; An, J; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Park, SH; Park, JO; Park, YS; Lim, HY; Kim, NKD; Park, W; Lee, H; Bass, AJ; Kim, K; Kang, WK; Lee, J

J CLIN PATHOL 2018 10.1136/jclinpath-2017-204535

Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis

Arora¹, K; Bal, M; Shih, A; Moy, A; Zukerberg, L; Brown, I; Liu, XL; Kelly, P; Oliva, E; Mullen, J; Ahn, S; Kim, KM; Deshpande, V

TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.008

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract

Lee¹, JY; Kim, K; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kwon, GY; Kim, KM; Lee, J; Lim, HY; Park, SH

CANCER DISCOV 2018 10.1158/2159-8290.CD-17-0395

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

Pectasides¹, E; Stachler, MD; Derks, S; Liu, Y; Maron, S; Islam, M; Alpert, L; Kwak, H; Kindler, H; Polite, B; Sharma, MR; Allen, K; O'Day, E; Lomnicki, S; Maranto, M; Kanteti, R; Fitzpatrick, C; Weber, C; Setia, N; Xiao, SY; Hart, J; Nagy, RJ; Kim, KM; Choi, MG; Min, BH; Nason, KS; O'Keefe, L; Watanabe, M; Baba, H; Lanman, R; Agoston, AT; Oh, DJ; Dunford, A; Thorner, AR; Ducar, MD; Wollison, BM; Coleman, HA; Ji, Y; Posner, MC; Roggin, K; Turaga, K; Chang, P; Hogarth, K; Siddiqui, UD; Gelrud, A; Ha, G; Freeman, SS; Rhoades, J; Reed, S; Gydush, G; Rotem, D; Davison, J; Imamura, Y; Adalsteinsson, V; Lee, J; Bass, AJ; Catenacci, DV

ONCOTARGET 2017 10.18632/oncotarget.22394

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines

Kim¹, JE; Kim, Y; Li, G; Kim, ST; Kim, K; Park, SH; Park, JO; Park, YS; Lim, HY; Lee, H; Sohn, TS; Kim, KM; Kang, WK; Lee, J

ONCOTARGET 2017 10.18632/oncotarget.22894

Measurement of tumor volume is not superior to diameter for prediction of lymph node metastasis in early gastric cancer with minute submucosal invasion

Pyo¹, JH; Byeon, SJ; Lee, H; Min, YW; Min, BH; Lee, JH; Kim, KM; Ahn, HS; Kim, K; Choi, YH; Kim, JJ

ONCOTARGET 2017 10.18632/oncotarget.18182

Correlation between MEK signature and Ras gene alteration in advanced gastric cancer

Ahn¹, S; Brant, R; Sharpe, A; Dry, JR; Hodgson, DR; Kilgour, E; Kim, K; Kim, ST; Park, SH; Kang, WK; Kim, KM; Lee, J

SURG ENDOSC 2017 10.1007/s00464-017-5490-4

Predictive factors for lymph node metastasis in early gastric cancer with lymphatic invasion after endoscopic resection

Park¹, JW; Ahn, S; Lee, H; Min, BH; Lee, JH; Rhee, PL; Kim, KM; Kim, JJ

HISTOPATHOLOGY 2017 10.1111/his.13292

Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases

Kang¹, G; Kang, Y; Kim, KH; Ha, SY; Kim, JY; Shim, YM; Heinrich, MC; Kim, KM; Corless, CL

NAT COMMUN 2017 10.1038/s41467-017-01470-y

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

Shin¹, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY

Oncoimmunology 2017 10.1080/2162402X.2017.1356150

Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity

Park¹, C; Cho, J; Lee, J; Kang, SY; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, ST; Park, SH; Park, JO; Kang, WK; Sohn, I; Jung, SH; Kang, MS; Kim, KM

ONCOTARGET 2017 10.18632/oncotarget.3750

MerTK is a novel therapeutic target in gastric cancer

Yi¹, JH; Jang, J; Cho, J; Do, IG; Hong, M; Kim, ST; Kim, KM; Lee, S; Park, SH; Park, JO; Park, YS; Kang, WK; Lim, HY; Lee, J

BREAST 2017 10.1016/j.breast.2017.07.006

Isolated pachymeningeal metastasis from breast cancer: Clinical features and prognostic factors

Heo¹, MH; Cho, YJ; Kim, HK; Kim, JY; Park, YH

ONCOLOGIST 2017 10.1634/theoncologist.2017-0020

Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials

Kim¹, ST; Kim, KM; Kim, NKD; Park, JO; Ahn, S; Yun, JW; Kim, KT; Park, SH; Park, PJ; Kim, HC; Sohn, TS; Il Choi, D; Cho, JH; Heo, JS; Kwon, W; Lee, H; Min, BH; Hong, SN; Park, YS; Lim, HY; Kang, WK; Park, WY; Lee, J

ONCOTARGET 2017 10.18632/oncotarget.20492

Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy

Kim¹, ST; Klempner, SJ; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Lee, J

J MOL DIAGN 2017 10.1016/j.jmoldx.2017.06.001

A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single-Nucleotide Variant Detection

Lee¹, C; Bae, JS; Ryu, GH; Kim, NKD; Park, D; Chung, J; Kyung, S; Joung, JG; Shin, HT; Shin, SH; Kim, Y; Kim, BS; Lee, H; Kim, KM; Kim, JS; Park, WY; Son, DS

ANN SURG ONCOL 2017 10.1245/s10434-017-5888-1

Comparison of Long-Term Outcomes After Non-curative Endoscopic Resection in Older Patients with Early Gastric Cancer

Pyo¹, JH; Lee, H; Min, BH; Lee, JH; Kim, KM; Yoo, H; Ahn, S; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, JJ; Kim, S

ONCOTARGET 2017 10.18632/oncotarget.19985

Development of mesenchymal subtype gene signature for clinical application in gastric cancer

Lee¹, J; Cristescu, R; Kim, KM; Kim, K; Kim, ST; Park, SH; Kang, WK

J Gastric Cancer 2017 10.5230/jgc.2017.17.e22

Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case

Kim¹, SM; An, JY; Choi, MG; Lee, JH; Sohn, TS; Kim, KM; Kim, S; Bae, JM

Appl Immunohistochem Mol Morphol 2017 10.1097/PAI.0000000000000360

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing

Murphy¹, DA; Ely, HA; Shoemaker, R; Boomer, A; Culver, BP; Hoskins, I; Haimes, JD; Walters, RD; Fernandez, D; Stahl, JA; Lee, J; Kim, KM; Lamoureux, J; Christiansen, J

TRANSL ONCOL 2017 10.1016/j.tranon.2017.03.001

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell Model

Jang¹, J; Kim, HK; Bang, H; Kim, ST; Kim, SY; Park, SH; Lim, HY; Kang, WK; Lee, J; Kim, KM

J Gastroenterol. 2017 May;52(5):594-601. doi: 10.1007/s00535-016-1254-5. Epub 2016 Sep 2.

Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis

Pyo JH1¹, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH3, Sohn TS2, Bae JM2, Kim KM4, Yeon S5, Jung SH5,6, Kim JJ1, Kim S2.

Gastrointest Endosc. 2017 Apr;85(4):730-736. doi: 10.1016/j.gie.2016.07.046. Epub 2016 Jul 27.

One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion

Kim TJ1¹, Lee H2, Min YW1, Min BH1, Lee JH1, Kim KM3, Kim MJ4, Kim K4, Rhee PL1, Kim JJ1.

Oncotarget. 2017 Mar 7;8(10):16233-16242. doi: 10.18632/oncotarget.9069.

IKK epsilon and TBK1 expression in gastric cancer

Lee SE1¹, Hong M2, Cho J3, Lee J4, Kim KM3.

Ann Oncol. 2017 Mar 1;28(3):547-554. doi: 10.1093/annonc/mdw669.

Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition

Kim ST1¹, Kim SY1, Klempner SJ2,3, Yoon J4, Kim N4, Ahn S4,5, Bang H5,6, Kim KM5,6, Park W4, Park SH1, Park JO1, Park YS1, Lim HY1, Lee SH1, Park K1,6, Kang WK1, Lee J1.

J Cancer. 2017 Feb 25;8(5):730-736. doi: 10.7150/jca.17887. eCollection 2017.

An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients

Lee JY1¹, Hong M2, Lee J3, Lee S3, Kim KM2, Park C4, Lim HY3.

Oncotarget. 2017 Feb 21;8(8):13320-13328. doi: 10.18632/oncotarget.14519.

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability

Cho J1¹, Lee J2, Bang H3, Kim ST2, Park SH2, An JY4, Choi MG4, Lee JH4, Sohn TS4, Bae JM4, Kang WK2, Kim S4, Kim KM3.

Oncotarget. 2017 Feb 28;8(9):15014-15022. doi: 10.18632/oncotarget.14788.

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion

Kim SY1¹, Ahn T2, Bang H3, Ham JS1, Kim J1, Kim ST1, Jang J1, Shim M1, Kang SY3, Park SH1, Min BH4, Lee H4, Kang WK1, Kim KM3, Park W2,5, Lee J1.

Oncotarget. 2017 Jan 10;8(2):3237-3245. doi: 10.18632/oncotarget.13700.

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors

Lim SH1¹, Kim SY1, Kim K2, Jang H1, Ahn S2, Kim KM2, Kim NK3, Park W3, Lee SJ1, Kim ST1, Park SH1, Park JO1, Park YS1, Lee SH1, Lim HY1, Park K1, Kang WK1, Lee J1.

J Mol Diagn. 2017 Jan;19(1):137-146. doi: 10.1016/j.jmoldx.2016.09.006. Epub 2016 Nov 10.

Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine

Kim S1¹, Park C2, Ji Y3, Kim DG3, Bae H1, van Vrancken M4, Kim DH5, Kim KM6.

Am J Surg Pathol. 2017 Jan;41(1):106-115.

High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications

Ahn S1¹, Lee SJ, Kim Y, Kim A, Shin N, Choi KU, Lee CH, Huh GY, Kim KM, Setia N, Lauwers GY, Park DY.

Helicobacter. 2016 Apr;21(2):153-7. doi: 10.1111/hel.12249. Epub 2015 Aug 7.

Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer

Camargo MC1¹, Kim KM2, Matsuo K3, Torres J4, Liao LM1, Morgan DR5, Michel A6, Waterboer T6, Zabaleta J7, Dominguez RL8, Yatabe Y9, Kim S10, Rocha-Guevara ER11, Lissowska J12, Pawlita M6, Rabkin CS1.

Sci Rep. 2016 Feb 25;6:22165. doi: 10.1038/srep22165.

Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection

Xiao H1¹, Zhang Y2, Kim Y3, Kim S4, Kim JJ5, Kim KM6, Yoshizawa J3, Fan LY1, Cao CX1, Wong DT3.

Oncotarget. 2016 Feb 16;7(7):7940-51. doi: 10.18632/oncotarget.6958.

The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients

Choi HS1¹,2, Ha SY3, Kim HM1,2, Ahn SM3, Kang MS4,5, Kim KM3, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kang ES2.

J Cancer. 2016 Feb 5;7(5):484-9. doi: 10.7150/jca.13711. eCollection 2016.

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs

Kim ST1¹, Ha SY2, Lee S1, Ahn S2, Lee J1, Park SH1, Park JO1, Lim HY1, Kang WK1, Kim KM2, Park YS1.

Ann Surg. 2016 Dec;264(6):1038-1043.

A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer

Pyo JH1¹, Shin CM, Lee H, Min BH, Lee JH, Kim SM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim KM, Kim HS, Jung SH, Kim JJ, Kim S; JHP and CMS contributed equally as the first authors of this study..

Ann Surg Oncol. 2016 Dec;23(Suppl 5):784-791. Epub 2016 Sep 9.

Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification

Pyo JH1¹, Ahn S2,3, Lee H4, Min BH1, Lee JH1, Shim SG5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim KM2, Yeon S7, Jung SH7,8, Kim JJ9, Kim S6.

J Pathol. 2016 Nov;240(3):304-314. doi: 10.1002/path.4777.

Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis

Min BH1¹, Hwang J2, Kim NK3, Park G2, Kang SY4, Ahn S4, Ahn S4, Ha SY4, Lee YK4, Kushima R5, Van Vrancken M6, Kim MJ7, Park C2, Park HY2,4, Chae J2, Jang SS2, Kim SJ8, Kim YH1, Kim JI9,10,11, Kim KM12.

Gastric Cancer. 2016 Oct;19(4):1104-13. doi: 10.1007/s10120-015-0570-4. Epub 2015 Nov 30.

Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep)

Kim JM1¹, Sohn JH2, Cho MY3, Kim WH4, Chang HK5, Jung ES6, Kook MC7, Jin SY8, Chae YS9, Park YS10, Kang MS11, Kim H12, Lee JH13, Park do Y14, Kim KM15, Kim H12, Kim YW16, Hwang SS17, Seol SY18, Jung HY19, Lee NR20, Park SH20, You JH20.

J Cancer. 2016 Oct 25;7(15):2173-2178. eCollection 2016.

To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients

Lee H1¹, Lee J2, Sohn I3, Park SH2, Park JO2, Park YS2, Kim KM4, Kang WK2, Kim ST2.

Cancer Res Treat. 2016 Oct;48(4):1155-1166. Epub 2016 Jun 24.

Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor

Koo DH1¹,2, Ryu MH2,3, Kim KM2,4, Yang HK2,5, Sawaki A6,7, Hirota S7,8, Zheng J9,10, Zhang B10,11, Tzen CY12, Yeh CN13, Nishida T7,14, Shen L10,15, Chen LT16,17, Kang YK2,3.

Gut Liver. 2016 Jan;10(1):63-8. doi: 10.5009/gnl14281.

Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer

Tae CH1¹,2, Lee JH1, Min BH1, Kim KM3, Rhee PL1, Kim JJ1.

Medicine (Baltimore). 2016 Jan;95(3):e2425. doi: 10.1097/MD.0000000000002425.

Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology

Lee M1¹, Chang MY, Shin HY, Shin E, Hong SW, Kim KM, Chay DB, Cho H, Kim JH.

Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26.

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Lim SH1¹, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.

Oncotarget. 2016 Jan 26;7(4):4024-35. doi: 10.18632/oncotarget.6602.

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors

Park C1¹, Ha SY1, Kim ST2, Kim HC3, Heo JS3, Park YS2, Lauwers G4, Lee J2, Kim KM1.

Mod Pathol. 2016 Sep;29(9):1095-103. doi: 10.1038/modpathol.2016.96. Epub 2016 May 27.

FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival

Ahn S1¹,2, Lee J3, Hong M4, Kim ST3, Park SH3, Choi MG5, Lee JH5, Sohn TS5, Bae JM5, Kim S5, Jung SH6, Kang WK3, Kim KM1,2.

Surg Endosc. 2016 Sep;30(9):3987-93. doi: 10.1007/s00464-015-4710-z. Epub 2015 Dec 22.

Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience

Lee JH1¹, Min YW1, Lee JH2, Kim ER1, Lee H1, Min BH1, Kim JJ1, Jang KT3, Kim KM3, Park CK3.

Clin Cancer Res. 2016 Aug 1;22(15):3831-40. doi: 10.1158/1078-0432.CCR-15-3000. Epub 2016 Mar 1.

Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target

Yakirevich E1¹, Resnick MB2, Mangray S2, Wheeler M2, Jackson CL2, Lombardo KA2, Lee J3, Kim KM4, Gill AJ5, Wang K6, Gowen K6, Sun J6, Miller VA6, Stephens PJ6, Ali SM6, Ross JS7, Safran H8.

Mol Diagn Ther. 2016 Aug;20(4):375-83. doi: 10.1007/s40291-016-0205-4.

A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer

Ahn S1¹,2, Hong M3, Van Vrancken M4, Lyou YJ2, Kim ST5, Park SH5, Kang WK5, Park YS5, Jung SH6, Woo M6, Lee J7, Kim KM8,9.

Mol Diagn Ther. 2016 Aug;20(4):347-51. doi: 10.1007/s40291-016-0203-6.

Detecting Primary KIT Mutations in Presurgical Plasma of Patients with Gastrointestinal Stromal Tumor

Kang G1¹, Sohn BS2, Pyo JS3, Kim JY1, Lee B4, Kim KM5.

Gastric Cancer. 2016 Jul;19(3):852-9. doi: 10.1007/s10120-015-0524-x. Epub 2015 Aug 12.

Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma

Min BH1¹, Tae CH1, Ahn SM2, Kang SY2, Woo SY3, Kim S3, Kim KM4.

Oncotarget. 2016 Jul 12;7(28):43492-43503. doi: 10.18632/oncotarget.9523.

MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis

Lee JY1¹, Lee I2, Chang WJ3, Ahn SM4,5, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Cho JH1, Kim SY1, Kim KM4,5, Lee S1, Kim ST1, Park SH1, Lee J1, Park JO1, Park YS1, Lim HY1, Kang WK1.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1231-7. doi: 10.1007/s00432-016-2143-2. Epub 2016 Mar 16.

Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)

Kim ST1¹, Ahn S2, Lee J1, Lee SJ1, Park SH1, Park YS1, Lim HY1, Kang WK1, Kim KM2, Park JO3.

Oncotarget. 2016 May 10;7(19):28670-83. doi: 10.18632/oncotarget.8764.

A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth

Park J1¹, Kim SY2, Kim HJ1, Kim KM1,3,4, Choi EY5, Kang MS1,4,5.

PLoS One. 2016 May 26;11(5):e0156207. doi: 10.1371/journal.pone.0156207. eCollection 2016.

A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer

Pyo JH1¹, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH2, Sohn TS2, Bae JM2, Kim KM3, Ahn HS4, Jung SH4,5, Kim S2, Kim JJ1.

Sci Rep. 2016 May 25;6:26732. doi: 10.1038/srep26732.

The minimal amount of starting DNA for Agilent's hybrid capture-based targeted massively parallel sequencing

Chung J1¹,2,3, Son DS1,2, Jeon HJ2, Kim KM4, Park G2, Ryu GH5, Park WY2,3, Park D1,2.

Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318.

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation

Kim N1¹,2, Cho A2, Watanabe H3,4, Choi YL2,5, Aziz M6, Kassner M6, Joung JG7, Park AK1,2, Francis JM8, Bae JS7, Ahn SM5, Kim KM5, Park JO9, Park WY2,7, Ahn MJ9, Park K9, Koo J10, Yin HH6, Cho J1,2,7.

Oncotarget. 2016 Feb 9;7(6):6538-51. doi: 10.18632/oncotarget.3731.

Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors

Kang G1¹,2, Yun H1,3, Sun CH3, Park I3, Lee S3, Kwon J3, Do I1,4,5, Hong ME1,5,6, Van Vrancken M1, Lee J7, Park JO7, Cho J8, Kim KM1,5, Sohn TS9.

Am J Gastroenterol. 2016 Feb;111(2):240-9. doi: 10.1038/ajg.2015.427. Epub 2016 Jan 19.

Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study

Pyo JH1¹, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH2, Sohn TS2, Bae JM2, Kim KM3, Ahn JH4, Carriere KC5, Kim JJ1, Kim S2.

Oncotarget. 2015 Sep 22;6(28):25619-30. doi: 10.18632/oncotarget.4627.

Patient-derived cell models as preclinical tools for genome-directed targeted therapy

Lee JY1¹, Kim SY1, Park C1, Kim NK2, Jang J1, Park K2, Yi JH3, Hong M4,5, Ahn T2, Rath O6, Schueler J6, Kim ST1, Do IG5, Lee S1, Park SH1, Ji YI7, Kim D7, Park JO1,4, Park YS1, Kang WK1, Kim KM4,5, Park WY2,7, Lim HY1, Lee J1,4.

PLoS One. 2015 Sep 11;10(9):e0137657. doi: 10.1371/journal.pone.0137657. eCollection 2015.

Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type

Jin DH1¹, Park SE1, Lee J2, Kim KM3, Kim S4, Kim DH1, Park J1.

Oncotarget. 2015 Sep 29;6(29):28211-22. doi: 10.18632/oncotarget.4721.

Gastrointestinal malignancies harbor actionable MET exon 14 deletions

Lee J1¹,2, Ou SH3, Lee JM4, Kim HC5, Hong M6, Kim SY1, Jang J1, Ahn S6, Kang SY6, Lee S1, Kim ST1, Kim B4, Choi J4, Kim KA4, Lee J1, Park C1,6, Park SH1, Park JO1,2, Lim HY1, Kang WK1, Park K1,2, Park YS1, Kim KM2,6.

Oncotarget. 2015 Sep 15;6(27):24320-32.

Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening

Lee J1¹, Kim HC2, Hong JY3, Wang K4, Kim SY1, Jang J1, Kim ST1, Park JO1, Lim HY1, Kang WK1, Park YS1, Lee J1, Lee WY2, Park YA2, Huh JW2, Yun SH2, Do IG5, Kim SH5, Balasubramanian S4, Stephens PJ4, Ross JS4,6, Li GG7, Hornby Z7, Ali SM4, Miller VA4, Kim KM5,8, Ou SH9.

PLoS Genet. 2015 Aug 21;11(8):e1005467. doi: 10.1371/journal.pgen.1005467. eCollection 2015.

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

Ji JH1¹, Oh YL2, Hong M2, Yun JW3, Lee HW2, Kim D4, Ji Y4, Kim DH4, Park WY3, Shin HT3, Kim KM2, Ahn MJ5, Park K5, Sun JM5.

Target Oncol. 2015 Dec;10(4):597-601. doi: 10.1007/s11523-015-0361-1. Epub 2015 Mar 5.

Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor

Kang G1¹, Bae BN2, Sohn BS3, Pyo JS4, Kang GH5, Kim KM6.

Surg Endosc. 2015 Dec;29(12):3460-8. doi: 10.1007/s00464-015-4095-z. Epub 2015 Feb 12.

Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer

Lee JH1¹, Lee JH2, Kim KM3, Kang KJ1, Min BH1, Kim JJ1.

Ann Surg. 2015 Dec;262(6):965-71. doi: 10.1097/SLA.0000000000001039.

New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma

Lee GD1¹, Lee SE, Kim KM, Kim YH, Ahn JH, Jung S, Choi YL, Kim HR, Park SI, Shim YM.

Oncotarget. 2015 Nov 17;6(36):39028-35. doi: 10.18632/oncotarget.5494.

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line

Lee SJ1¹, Li GG2, Kim ST1, Hong ME3, Jang J1, Yoon N3, Ahn SM3, Murphy D2, Christiansen J2, Wei G2, Hornby Z2, Lee DW4, Park JO1,5, Park YS1, Lim HY1, Hong SN6, Kim SH3, Kang WK1, Park K1, Park WY7, Kim KM3,5, Lee J1.

Oncotarget. 2015 Nov 10;6(35):38372-80. doi: 10.18632/oncotarget.5368.

Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens

Ahn S1¹,2, Ahn S1,3, Van Vrancken M1, Lee M1, Ha SY1, Lee H4, Min BH4, Lee JH4, Kim JJ4, Choi S5, Jung SH5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim KM1,3.

Oncotarget. 2015 Nov 24;6(37):40360-9. doi: 10.18632/oncotarget.5465.

Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients

Kim ST1¹, Lee WS2, Lanman RB3, Mortimer S3, Zill OA3, Kim KM4,5, Jang KT5, Kim SH5, Park SH1, Park JO1,4, Park YS1, Lim HY1, Eltoukhy H3, Kang WK1, Lee WY6, Kim HC6, Park K1,4, Lee J1,4, Talasaz A3.

J Clin Oncol. 2015 Oct 1;33(28):3130-6. doi: 10.1200/JCO.2014.58.3930. Epub 2015 Jan 5.

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

Park SH1¹, Sohn TS1, Lee J1, Lim DH1, Hong ME1, Kim KM1, Sohn I1, Jung SH1, Choi MG1, Lee JH1, Bae JM1, Kim S1, Kim ST1, Park JO1, Park YS1, Lim HY1, Kang WK2.

Cancer Res Treat. 2015 Oct;47(4):813-22. doi: 10.4143/crt.2014.238. Epub 2015 Feb 26.

Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters

Gastrointestinal Pathology Study Group of Korean Society of Pathologists¹, Sohn JH1, Cho MY2, Park Y3, Kim H4, Kim WH5, Kim JM6, Jung ES7, Kim KM8, Lee JH9, Chan HK10, Park do Y11, Joo M12, Kim S13, Moon WS14, Kang MS15, Jin SY16, Kang YK17, Yoon SO18, Han H19, Choi E20.

Oncotarget. 2015 Oct 20;6(32):33358-68. doi: 10.18632/oncotarget.5188.

The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis

Kim ST1¹, Lee J1, Hong M2,3, Park K4,5, Park JO1, Ahn T3,4, Park SH1, Park YS1, Lim HY1, Sun JM1, Ahn JS1, Ahn MJ1, Kim HC6, Sohn TS6, Choi DI7, Cho JH8, Heo JS6, Kwon W6, Uhm SW9, Lee H10, Min BH10, Hong SN10, Kim DH5,11, Jung SH12, Park W4,5, Kim KM2,3, Kang WK1, Park K1,2.

Br J Surg. 2015 Oct;102(11):1394-401. doi: 10.1002/bjs.9873. Epub 2015 Aug 27.

Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer

Kim ER1¹, Lee H1, Min BH1, Lee JH1, Rhee PL1, Kim JJ1, Kim KM2, Kim S3.

Medicine (Baltimore). 2015 Oct;94(40):e1622. doi: 10.1097/MD.0000000000001622.

Feasibility and Diagnostic Yield of Endoscopic Ultrasonography-Guided Fine Needle Biopsy With a New Core Biopsy Needle Device in Patients With Gastric Subepithelial Tumors

Lee M1¹, Min BH, Lee H, Ahn S, Lee JH, Rhee PL, Kim JJ, Sohn TS, Kim S, Kim KM.

Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16.

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopatholoqical Analysis of 72 Cases in a Single Institute

Shin Y1¹, Ha SY1, Hyeon J1, Lee B1, Lee J2, Jang KT1, Kim KM1, Park YS2, Park CK1.

Ann Oncol. 2015 Jan;26(1):161-6. doi: 10.1093/annonc/mdu504. Epub 2014 Oct 29.

Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing

Sun JM1¹, Choi YL2, Ji JH3, Ahn JS1, Kim KM2, Han J2, Ahn MJ1, Park K4.

Eur J Radiol. 2015 Jan;84(1):33-40. doi: 10.1016/j.ejrad.2014.10.020. Epub 2014 Nov 8.

Gastrointestinal stromal tumours: Correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker

Kang TW1¹, Kim SH2, Jang KM1, Choi D1, Ha SY3, Kim KM3, Kang WK4, Kim MJ5.

Endoscopy. 2015 Sep;47(9):784-93. doi: 10.1055/s-0034-1392249. Epub 2015 Jun 25.

Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer

Min BH1¹, Kim ER1, Kim KM2, Park CK2, Lee JH1, Rhee PL1, Kim JJ1.

Transl Oncol. 2015 Aug;8(4):288-94. doi: 10.1016/j.tranon.2015.06.001.

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer

Kim ST1¹, Jang HL2, Lee J1, Park SH1, Park YS1, Lim HY1, Choi MG3, Bae JM3, Sohn TS3, Noh JH3, Kim S3, Kim KM4, Kang WK1, Park JO5.

Oncotarget. 2015 Aug 21;6(24):20190-203.

Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun

Jin DH1¹, Lee J2, Kim KM3, Kim S4, Kim DH1, Park J1.

Gastric Cancer. 2015 Jul;18(3):618-26. doi: 10.1007/s10120-014-0378-7. Epub 2014 May 7.

Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity

Min BH1¹, Kim KM, Park CK, Lee JH, Rhee PL, Rhee JC, Kim JJ.

Surg Endosc. 2015 Jun;29(6):1614-20. doi: 10.1007/s00464-014-3852-8. Epub 2014 Oct 8.

Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric cancers: analysis of a large surgical database

Tae CH1¹, Pouw RE, Duits LC, Sung YK, Min BH, Lee JH, Rhee PL, Kim KM, Bergman JJ, Kim JJ.

Clin Transl Oncol. 2015 Jun;17(6):462-8. doi: 10.1007/s12094-014-1258-7. Epub 2014 Dec 2.

The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer

Kim ST1¹, Do IG, Lee J, Sohn I, Kim KM, Kang WK.

Int J Cancer. 2015 May 15;136(10):2284-92. doi: 10.1002/ijc.29286. Epub 2014 Nov 6.

GAGE12 mediates human gastric carcinoma growth and metastasis

Lee EK1¹, Song KA, Chae JH, Kim KM, Kim SH, Kang MS.

Nat Med. 2015 May;21(5):449-56. doi: 10.1038/nm.3850. Epub 2015 Apr 20.

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Cristescu R1¹, Lee J2, Nebozhyn M1, Kim KM3, Ting JC4, Wong SS4, Liu J4, Yue YG4, Wang J4, Yu K4, Ye XS4, Do IG3, Liu S5, Gong L5, Fu J6, Jin JG6, Choi MG7, Sohn TS7, Lee JH7, Bae JM7, Kim ST2, Park SH2, Sohn I8, Jung SH8, Tan P9, Chen R1, Hardwick J1, Kang WK2, Ayers M1, Hongyue D1, Reinhard C4, Loboda A1, Kim S7, Aggarwal A4.

Int J Cancer. 2015 Apr 1;136(7):1629-35. doi: 10.1002/ijc.29159. Epub 2014 Sep 4.

HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy

Ha SY1¹, Lee J, Jang J, Hong JY, Do IG, Park SH, Park JO, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Kang WK, Kim KM.

Int J Cancer. 2015 Apr 1;136(7):1568-78. doi: 10.1002/ijc.29133. Epub 2014 Aug 22.

Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers

Kang SY1¹, Park CK, Chang DK, Kim JW, Son HJ, Cho YB, Yun SH, Kim HC, Kwon M, Kim KM.

Diagn Pathol. 2015 Apr 30;10:46. doi: 10.1186/s13000-015-0281-5.

Exuberant squamous metaplasia of the gastric mucosa in a patient with gastric adenocarcinoma

Ahn S1¹, Bae GE2, Kim KM3.

J Surg Res. 2015 Apr;194(2):458-63. doi: 10.1016/j.jss.2014.12.005. Epub 2014 Dec 8.

Lymphoepithelioma-like carcinoma: A distinct type of gastric cancer

Park S1¹, Choi MG2, Kim KM3, Kim HS4, Jung SH4, Lee JH1, Noh JH1, Sohn TS1, Bae JM1, Kim S1.

J Gastrointest Surg. 2015 Apr;19(4):631-8. doi: 10.1007/s11605-014-2708-9. Epub 2014 Dec 4.

Preoperative Predictive Factors for Gastrointestinal Stromal Tumors: Analysis of 375 Surgically Resected Gastric Subepithelial Tumors

Min YW1¹, Park HN, Min BH, Choi D, Kim KM, Kim S.

Clin Infect Dis. 2015 Mar 15;60(6):e20-6. doi: 10.1093/cid/ciu969. Epub 2014 Dec 1.

Clinical Presentation and Risk Factors for Cytomegalovirus Colitis in Immunocompetent Adult Patients

Ko JH1¹, Peck KR1, Lee WJ1, Lee JY1, Cho SY1, Ha YE1, Kang CI1, Chung DR1, Kim YH2, Lee NY3, Kim KM4, Song JH1.

Gut Liver. 2015 Mar;9(2):202-7. doi: 10.5009/gnl13352.

The Role of the CpG Island Methylator Phenotype on Survival Outcome in Colon Cancer

Kang KJ1¹, Min BH2, Ryu KJ2, Kim KM3, Chang DK2, Kim JJ2, Rhee JC2, Kim YH2.

Sci Rep. 2015 Mar 19;5:9289. doi: 10.1038/srep09289.

The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer

Lee JY1¹, Hong M2, Kim ST1, Park SH1, Kang WK1, Kim KM2, Lee J1.

Gastroenterology. 2015 Jan;148(1):137-147.e9. doi: 10.1053/j.gastro.2014.09.020. Epub 2014 Sep 22.

Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes

Kim SY1¹, Park C2, Kim HJ3, Park J1, Hwang J4, Kim JI5, Choi MG6, Kim S6, Kim KM7, Kang MS8.

Clin Radiol. 2014 Aug;69(8):827-35. doi: 10.1016/j.crad.2014.03.017. Epub 2014 May 16.

Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: Comparison with two-dimensional multidetector row CT

Jang KM1¹, Kim SH2, Lee SJ1, Lee MW1, Choi D1, Kim KM3.

Clin Genet. 2014 Jul;86(1):37-43. doi: 10.1111/cge.12408. Epub 2014 May 10.

Innovative personalized medicine in gastric cancer: time to move forward

Lee J1¹, Kim KM, Kang WK, Ou SH.

Invest New Drugs. 2014 Jun;32(3):535-41. doi: 10.1007/s10637-014-0065-x. Epub 2014 Jan 28.

Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab

Lee J1¹, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, Cho YB, Lee WY, Yun SH, Kim HC, Park YS, Kang WK.

World J Gastroenterol. 2014 Feb 7;20(5):1365-70. doi: 10.3748/wjg.v20.i5.1365.

Epstein-Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection: Case series

Lee JY1¹, Kim KM1, Min BH1, Lee JH1, Rhee PL1, Kim JJ1.

Sci Rep. 2014 Dec 23;4:7592. doi: 10.1038/srep07592.

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer

Yi JH1¹, Do IG2, Jang J3, Kim ST3, Kim KM4, Park SH3, Park JO3, Park YS3, Lim HY3, Kang WK3, Lee J3.

Asia Pac J Clin Oncol. 2014 Dec;10(4):297-307. doi: 10.1111/ajco.12263. Epub 2014 Sep 16.

Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an Asia-Pacific Task Force

Kim KM1¹, Bilous M, Chu KM, Kim BS, Kim WH, Park YS, Ryu MH, Sheng W, Wang J, Chao Y, Ying J, Zhang S.

PLoS One.?2014 Nov 5;9(11):e111693. doi: 10.1371/journal.pone.0111693. eCollection 2014.

High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer

Kim S1¹,?Lee J2,?Hong ME3,?Do IG3,?Kang SY1,?Ha SY1,?Kim ST2,?Park SH2,?Kang WK2,?Choi MG4,?Lee JH4,?Sohn TS4,?Bae JM4,?Kim S4,?Kim DH5,?Kim KM3.

Mol Cancer Ther. 2014 Nov;13(11):2527-36. doi: 10.1158/1535-7163.MCT-14-0255. Epub 2014 Sep 23.

Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification

Kim ST1¹, Jang HL2, Lee SJ1, Lee J1, Choi YL3, Kim KM3, Cho J4, Park SH1, Park YS1, Lim HY1, Yashiro M5, Kang WK1, Park JO6.

Nat Commun. 2014 Nov 19;5:5477. doi: 10.1038/ncomms6477.

Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

Wong SS1¹, Kim KM2, Ting JC1, Yu K1, Fu J3, Liu S4, Cristescu R5, Nebozhyn M5, Gong L4, Yue YG1, Wang J1, Ronghua C5, Loboda A5, Hardwick J5, Liu X5, Dai H5, Jin JG3, Ye XS1, Kang SY2, Do IG2, Park JO6, Sohn TS7, Reinhard C1, Lee J6, Kim S7, Aggarwal A1.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1847-53. doi: 10.1007/s10096-014-2107-x. Epub 2014 May 23.

Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer

Ko JH1¹, Peck KR, Lee WJ, Huh K, Yoo JR, Kim K, Cho SY, Ha YE, Kang CI, Chung DR, Jung CW, Kim YH, Lee NY, Kim KM, Song JH.

Dig Dis Sci. 2014 Oct;59(10):2536-43. doi: 10.1007/s10620-014-3196-1. Epub 2014 Aug 9.

Endoscopic Resection for Undifferentiated Early Gastric Cancer: Focusing on Histologic Discrepancies Between Forceps Biopsy-Based and Endoscopic Resection Specimen-Based Diagnosis

Min BH1¹, Kang KJ, Lee JH, Kim ER, Min YW, Rhee PL, Kim JJ, Rhee JC, Kim KM.

Oncol Lett. 2014 Oct;8(4):1665-1669. Epub 2014 Jul 8.

C-KIT-positive undifferentiated tumor of the liver: A case report

Chu HH1¹, Cho BH2, Song JS3, Kim KM4, Moon WS1.

Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03625.

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling

Park S1¹, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL4.

Am J Surg Pathol. 2014 Jun;38(6):784-92. doi: 10.1097/PAS.0000000000000185.

Pyloric Gland Adenoma in Lynch Syndrome

Lee SE1¹, Kang SY, Cho J, Lee B, Chang DK, Woo H, Kim JW, Park HY, Do IG, Kim YE, Kushima R, Lauwers GY, Park CK, Kim KM.

Ann Surg Oncol. 2014 Apr;21(4):1099-106. doi: 10.1245/s10434-013-3339-1. Epub 2013 Dec 4.

CD151 Overexpression is Associated with Poor Prognosis in Patients with pT3 Gastric Cancer

Ha SY1¹, Do IG, Lee J, Park SH, Park JO, Kang WK, Choi MG, Lee JH, Bae JM, Kim S, Kim KM, Sohn TS.

PLoS One. 2014 Mar 5;9(3):e90133. doi: 10.1371/journal.pone.0090133. eCollection 2014.

Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery

Lee J1¹, Sohn I2, Do IG3, Kim KM4, Park SH1, Park JO1, Park YS1, Lim HY1, Sohn TS5, Bae JM5, Choi MG5, Lim do H6, Min BH7, Lee JH7, Rhee PL7, Kim JJ7, Choi DI8, Tan IB9, Das K10, Tan P11, Jung SH2, Kang WK1, Kim S5.

Diagn Pathol. 2014 Feb 20;9:34. doi: 10.1186/1746-1596-9-34.

Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion

Lee SM¹, Yang S, Joo M, Kim KM1, Park CK, Ahn S, Min BH, Lee JH, Kim S, Rhee JC, Kim JJ, Lauwers GY.

Gut. 2014 Feb;63(2):236-43. doi: 10.1136/gutjnl-2013-304531. Epub 2013 Apr 12.

Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis

Camargo MC1¹, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS.

J Pediatr Hematol Oncol. 2014 Jan;36(1):e61-4. doi: 10.1097/MPH.0b013e31829dd114.

Melanotic Neuroectodermal Tumor of Infancy Disseminated by a Ventriculoperitoneal Shunt and Diagnosed from the Inguinal Sac

Yoo IH1¹, Yum SK, Oh SJ, Kim KM, Jeong DC.

Mod Pathol.?2013 Dec;26(12):1632-41. doi: 10.1038/modpathol.2013.108. Epub 2013 Jun 28.

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

Ha SY1¹,?Lee J,?Kang SY,?Do IG,?Ahn S,?Park JO,?Kang WK,?Choi MG,?Sohn TS,?Bae JM,?Kim S,?Kim M,?Kim S,?Park CK,?Ignatius Ou SH,?Kim KM.

PLoS One. 2013 Dec 23;8(12):e82770. doi: 10.1371/journal.pone.0082770. eCollection 2013.

Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer

Kang G1¹, Hwang WC2, Do IG3, Wang K4, Kang SY3, Lee J5, Park SH5, Park JO5, Kang WK5, Jang J5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim MJ7, Kim S7, Park CK3, Kim KM3.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84. doi: 10.1245/s10434-012-2818-0. Epub 2012 Dec 30.

A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages

Cho J1¹, Jeong J, Sung J, Sung CO, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.

APMIS. 2013 Oct;121(10):938-44. doi: 10.1111/apm.12085. Epub 2013 Jun 12.

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases

Kang G1¹, Park YS, Jung ES, Joo M, Kang MS, Ahn S, Kang GH, Kim KM.

PLoS One. 2013 Oct 4;8(10):e77219. doi: 10.1371/journal.pone.0077219. eCollection 2013.

GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors

Lee EJ1¹, Kang G, Kang SW, Jang KT, Lee J, Park JO, Park CK, Sohn TS, Kim S, Kim KM.

Korean J Pathol.?2013 Aug;47(4):348-54. doi: 10.4132/KoreanJPathol.2013.47.4.348. Epub 2013 Aug 26.

Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples

Ahn S1¹,?Lee J,?Sung JY,?Kang SY,?Ha SY,?Jang KT,?Choi YL,?Kim JS,?Oh YL,?Kim KM.

No items found.

High Proportion of Granzyme B plus Intraepithelial Lymphocytes Contributes to Epithelial Apoptosis in Helicobacter pylori-Associated Lymphocytic Gastritis

Diagn Pathol. 2013 Jul 24;8:121. doi: 10.1186/1746-1596-8-121.

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Kang SY¹, Ahn S, Lee SM, Jeong JY, Sung JY, Oh YL, Kim KM.

Anal Quant Cytopathol Histpathol.?2013 Jun;35(3):146-51.

A Comparative Study of Telomerase Activity and Cytologic Diagnosis in Malignant Ascites

Park ES1¹,?Lee J2,?Kang SY3,?Lee EJ1,?Lee MH4,?Yoon N3,?Oh YL3,?Kim KM3.

Korean J Pathol. 2013 Jun;47(3):227-37. doi: 10.4132/KoreanJPathol.2013.47.3.227. Epub 2013 Jun 25.

Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters

Gastrointestinal Pathology Study Group of Korean Society of Pathologists¹, Cho MY, Sohn JH, Jin SY, Kim H, Jung ES, Kim MJ, Kim KM, Kim WH, Kim JM, Kang YK, Choi JH, Kang DY, Kim YW, Choi EH.

Mod Pathol. 2013 May;26(5):677-84. doi: 10.1038/modpathol.2012.205. Epub 2012 Dec 14.

Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas

Cho EY1¹, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S.

Cancer.?2013 May 1;119(9):1627-35. doi: 10.1002/cncr.27967. Epub 2013 Feb 7.

Identification of ROS1 Rearrangement in Gastric Adenocarcinoma

Lee J1¹,?Lee SE,?Kang SY,?Do IG,?Lee S,?Ha SY,?Cho J,?Kang WK,?Jang J,?Ou SH,?Kim KM.

Histol Histopathol. 2013 Apr;28(4):453-62. Epub 2013 Feb 13.

Serrated adenoma of the stomach: A clinicopathologic, immunohistochemical, and molecular study of nine cases

Kwon MJ1¹, Min BH, Lee SM, Park HY, Kang SY, Ha SY, Lee JH, Kim JJ, Park CK, Kim KM.

Anal Quant Cytopathol Histpathol. 2013 Feb;35(1):27-35.

Heterogeneous Target Protein Expression in Synchronous Multiple Gastric Carcinomas

Kang G1¹, Park HY, Ahn S, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.

J Surg Oncol. 2012 Nov;106(6):777-82. doi: 10.1002/jso.23131. Epub 2012 Apr 18.

EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas

Park HY1¹, Kang SY, Kang GH, Bae GE, Lee SE, Kim KM, Park CK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.

J Surg Oncol. 2012 Nov;106(6):757-64. doi: 10.1002/jso.23141. Epub 2012 Apr 25.

Tumor size predicts survival in mucinous gastric carcinoma

Sung CO1¹, Lee SM, Choi JS, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim WH, Park CK, Kim S.

Endoscopy. 2012 Oct;44(10):949-52. doi: 10.1055/s-0032-1310161. Epub 2012 Sep 17.

Gastric extremely well-differentiated intestinal-type adenocarcinoma: a challenging lesion to achieve complete endoscopic resection

Kang KJ1¹, Kim KM, Kim JJ, Rhee PL, Lee JH, Min BH, Rhee JC, Kushima R, Lauwers GY.

Pathology.?2012 Aug;44(5):460-4. doi: 10.1097/PAT.0b013e3283559c45.

Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours

Kang G1¹,?Lee J,?Jang KT,?Beadling C,?Corless CL,?Heinrich MC,?Park JO,?Kang WK,?Park CK,?Kim KM.

Diagn Pathol. 2012 Aug 15;7:102. doi: 10.1186/1746-1596-7-102.

Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma

Lee SM1¹, Ahn S, Lee YK, Jang KT, Park CK, Kim KM.

Korean J Pathol. 2012 Jun;46(3):292-6. doi: 10.4132/KoreanJPathol.2012.46.3.292. Epub 2012 Jun 22.

Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: Report of Two Cases and Review of the Literature

Kang Y1¹, Jung W, Do IG, Lee EJ, Lee MH, Kim KM, Choi J.

PLoS One.?2012;7(6):e38892. doi: 10.1371/journal.pone.0038892. Epub 2012 Jun 18.

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

Lee J1¹,?van Hummelen P,?Go C,?Palescandolo E,?Jang J,?Park HY,?Kang SY,?Park JO,?Kang WK,?MacConaill L,?Kim KM.

J Korean Med Sci. 2010 Nov;25(11):1543-52. doi: 10.3346/jkms.2010.25.11.1543. Epub 2010 Oct 26.

Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea

Kang YK1¹, Kim KM, Sohn T, Choi D, Kang HJ, Ryu MH, Kim WH, Yang HK; Korean GIST Study Group.

Pathology. 2012 Jun;44(4):385; author reply 386. doi: 10.1097/PAT.0b013e328353fffe.

Filiform serrated adenoma: authors' reply

¹,Holck S.

Korean J Pathol. 2012 Jun;46(3):287-91. doi: 10.4132/KoreanJPathol.2012.46.3.287. Epub 2012 Jun 22.

Gastric Adenocarcinoma of Fundic Gland Type: Report of Three Cases

Park ES1¹, Kim YE, Park CK, Yao T, Kushima R, Kim KM.

PLoS One.?2012;7(4):e34456. doi: 10.1371/journal.pone.0034456. Epub 2012 Apr 2.

Metastasis of Neuroendocrine Tumors Are Characterized by Increased Cell Proliferation and Reduced Expression of the ATM Gene

Lee J1¹,?Sung CO,?Lee EJ,?Do IG,?Kim HC,?Yoon SH,?Lee WY,?Chun HK,?Kim KM,?Park YS.

Acta Oncol. 2012 Apr;51(4):528-36. doi: 10.3109/0284186X.2011.636753. Epub 2011 Dec 7.

Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study

Kang HJ1¹, Ryu MH, Kim KM, Park YS, Choi J, Ryoo BY, Kim WH, Im SA, Bang YJ, Park SH, Lee JH, Chung IJ, Bae HI, Kim JG, Lee KH, Song HS, Kwon HC, Baek JH, Shin DB, Lee KE, Kang YK.

Pathology. 2012 Apr;44(3):260-1. doi: 10.1097/PAT.0b013e32834e42f5.

Aggressive gastrointestinal stromal tumour of the oesophagus with homozygous KIT exon 11 deletion mutation

Cho J¹, Kang GH, Kim KM, Park J, Shim YM.

Pathology. 2012 Apr;44(3):216-20. doi: 10.1097/PAT.0b013e3283513e8b.

Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas

Cho EY1¹, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S.

Pathology. 2012 Jan;44(1):18-23. doi: 10.1097/PAT.0b013e32834d7bbf.

Filiform serrated adenoma is an unusual, less aggressive variant of traditional serrated adenoma

Ha SY1¹, Lee SM, Lee EJ, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Kim KM.

Gut Liver. 2012 Jan;6(1):52-7. doi: 10.5009/gnl.2012.6.1.52. Epub 2012 Jan 12.

Glomus Tumor of the Stomach: A Clinicopathologic Analysis of 10 Cases and Review of the Literature

Kang G1¹, Park HJ, Kim JY, Choi D, Min BH, Lee JH, Kim JJ, Kim KM, Park CK, Sohn TS, Kim S.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

Molecular Features of Colorectal Hyperplastic Polyps and Sessile Serrated Adenoma/Polyps From Korea

Kim KM1¹, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

BMC Cancer. 2011 Aug 10;11:344. doi: 10.1186/1471-2407-11-344.

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

Min BH1¹, Bae JM, Lee EJ, Yu HS, Kim YH, Chang DK, Kim HC, Park CK, Lee SH, Kim KM, Kang GH.

SSTR2A Protein Expression in Neuroendocrine Neoplasms of the Colorectum

Gut Liver. 2011 Jun;5(2):143-8. doi: 10.5009/gnl.2011.5.2.143. Epub 2011 Jun 24.

Pathology of Epstein-Barr Virus-Associated Gastric Carcinoma and Its Relationship to Prognosis

Song HJ1¹, Kim KM.

World J Gastroenterol. 2011 Jun 7;17(21):2602-10. doi: 10.3748/wjg.v17.i21.2602.

Diagnosis of gastric epithelial neoplasia: Dilemma for Korean pathologists

Kim JM1¹, Cho MY, Sohn JH, Kang DY, Park CK, Kim WH, Jin SY, Kim KM, Chang HK, Yu E, Jung ES, Chang MS, Joo JE, Joo M, Kim YW, Park do Y, Kang YK, Park SH, Han HS, Kim YB, Park HS, Chae YS, Kwon KW, Chang HJ; Gastrointestinal Pathology Study Group of Korean Society of Pathologists.

APMIS.?2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24.

KIT amplification and gene mutations in acral/mucosal melanoma in Korea

Yun J1¹,?Lee J,?Jang J,?Lee EJ,?Jang KT,?Kim JH,?Kim KM.

Mod Pathol. 2011 Jun;24(6):866-75. doi: 10.1038/modpathol.2011.11. Epub 2011 Feb 25.

DOG1 and PKC-theta are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors

Kang GH1¹, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, Kim S, Kang DY, Kim KM.

Pathology. 2010 Dec;42(7):684-6. doi: 10.3109/00313025.2010.523686.

Coexistence of EBV associated nasopharyngeal undifferentiated carcinoma and gastric lymphoepithelioma-like carcinoma

Lee SM¹, Oh YL, Kim KM, Ko YH, Lee J.

Prognostic Significance of Methylation Profiles in Urothelial Carcinomas of the Bladder

Cancer Res Treat. 2012 Jun;44(2):85-96. doi: 10.4143/crt.2012.44.2.85. Epub 2012 Jun 30.

Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea

Kang YK1¹, Kang HJ, Kim KM, Sohn T, Choi D, Ryu MH, Kim WH, Yang HK; Korean GIST Study Group (KGSG).

Am J Surg Pathol. 2010 Aug;34(8):1139-46. doi: 10.1097/PAS.0b013e3181e7043b.

Micropapillary Carcinoma of Stomach A Clinicopathologic and Immunohistochemical Study of 11 Cases

Roh JH1¹, Srivastava A, Lauwers GY, An J, Jang KT, Park CK, Sohn TS, Kim S, Kim KM.

J Korean Med Sci. 2010 Jun;25(6):853-62. doi: 10.3346/jkms.2010.25.6.853. Epub 2010 May 24.

Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004 (vol 25, pg 853, 2010)

Cho MY1¹, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, Jung JS, Jung ES, Jin SY, Kang DY, Park JB, Park HS, Choi YD, Sung SH, Kim YB, Kim H, Bae YK, Kang M, Chang HJ, Chae YS, Lee HE, Park do Y, Lee YS, Kang YK, Kim HK, Chang HK, Hong SW, Choi YH, Shin O, Gu M, Kim YW, Kim GI, Chang SJ.

Gastroenterology. 2010 Jul;139(1):84-92.e2. doi: 10.1053/j.gastro.2010.04.002. Epub 2010 Apr 14.

Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus-Associated Gastric Carcinoma

Song HJ1¹, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK, Kim S.

J Korean Med Sci. 2010 Jun;25(6):853-62. doi: 10.3346/jkms.2010.25.6.853. Epub 2010 May 24.

Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004

Cho MY1¹, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, Jung JS, Jung ES, Jin SY, Kang DY, Park JB, Park HS, Choi YD, Sung SH, Kim YB, Kim H, Bae YK, Kang M, Chang HJ, Chae YS, Lee HE, Park do Y, Lee YS, Kang YK, Kim HK, Chang HK, Hong SW, Choi YH, Shin O, Gu M, Kim YW, Kim GI, Chang SJ.

Am J Surg Pathol. 2010 May;34(5):667-75. doi: 10.1097/PAS.0b013e3181d40cb2.

KRAS Mutations in Traditional Serrated Adenomas From Korea Herald an Aggressive Phenotype

Kim KM1¹, Lee EJ, Kim YH, Chang DK, Odze RD.

Gastroenterology. 2010 Jul;139(1):84-92.e2. doi: 10.1053/j.gastro.2010.04.002. Epub 2010 Apr 14.

Expression of HSP90 in gastrointestinal stromal tumours and mesenchymal tumours

Song HJ1¹, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK, Kim S.

Pathology. 2010 Jan;42(1):54-7. doi: 10.3109/00313020903434413.

WT-1 expression in gastrointestinal stromal tumours

Kang GH1¹, Kim KM, Noh JH, Sohn TS, Kim S, Park CK, Lee CS, Kang DY.

Pathology. 2009;41(6):593-5.

EBV-associated lymphoepithelioma-like gastric carcinoma in a patient with HIV

Kim J¹, Kim KM, Noh JH, Park CK.

Pathology. 2009;41(6):595-6.

Microcystic/reticular schwannoma in the colon

Lee SM¹, Goldblum J, Kim KM.

Yonsei Med J. 2009 Oct 31;50(5):709-12. doi: 10.3349/ymj.2009.50.5.709. Epub 2009 Oct 21.

Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea

Song HJ1¹, Kim KM, Choi DI, Park CK.

Histopathology. 2009 Sep;55(3):368-9. doi: 10.1111/j.1365-2559.2009.03368.x.

PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour

Kang GH¹, Kim KM, Park CK, Kang DY.

Gastrointestinal Stromal Tumor of the Colon Mimicking Inflammatory Fibroid Polyp with a Novel 63 bp c-kit Deletion Mutation - A Case Report

No items found.

Loss of Heterozygosity on Chromosome 15q15 Near Thrombospondin-1 Gene in Breast Carcinomas

Hum Pathol. 2009 Jun;40(6):868-71. doi: 10.1016/j.humpath.2008.11.013. Epub 2009 Mar 9.

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors

Kim YR1¹, Kim KM, Yoo NJ, Lee SH.

APMIS. 2009 Feb;117(2):87-94. doi: 10.1111/j.1600-0463.2008.00017.x.

Prognostic significance of O-6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas

Lee SM1¹, Lee EJ, Ko YH, Lee SH, Maeng L, Kim KM.

Mod Pathol. 2009 Feb;22(2):314-20. doi: 10.1038/modpathol.2008.194. Epub 2008 Dec 5.

Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma

Sinn DH1¹, Kim YH, Lee EJ, Ko YH, Kim KM.

Clin Cancer Res. 2009 Jan 1;15(1):291-8. doi: 10.1158/1078-0432.CCR-08-0848.

Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Carcinoma Patients Receiving Adjuvant Chemotherapy and Is Not Associated with EBV Infection

Park ES1¹, Do IG, Park CK, Kang WK, Noh JH, Sohn TS, Kim S, Kim MJ, Kim KM.

Pathology. 2009;41(4):396-7. doi: 10.1080/00313020902886977.

Gastrointestinal stromal tumour with osteoclast-like giant cells and aneurysmal bone cyst-like features

Do IG¹, Park CK, Kim KM.

Acta Haematol. 2008;120(4):217-24. doi: 10.1159/000195698. Epub 2009 Jan 28.

Methylation of p16(INK4A) and Mitotic Arrest Defective Protein 2 (MAD2) Genes in Gastric Marginal-Zone B-Cell Lymphomas

Park S1¹, Kim KM, Kim JJ, Lee JH, Rhee JC, Ko YH.

Pathology. 2008 Oct;40(6):553-7. doi: 10.1080/00313020802320440.

Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers

Kim SY1¹, Oh YL, Kim KM, Jeong EG, Kim MS, Yoo NJ, Lee SH.

Ann Surg. 2008 Jun;247(6):1011-8. doi: 10.1097/SLA.0b013e3181724f9d.

Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy

Keun Park C1¹, Lee EJ, Kim M, Lim HY, Choi DI, Noh JH, Sohn TS, Kim S, Kim MJ, Lee HK, Kim KM.

Pathology. 2008 Jan;40(1):83-5.

Metastatic renal cell carcinoma masquerading as a primary gastric carcinoma associated with synchronous early gastric carcinoma

Roh JH¹, Kim HJ, Jang KT, Kim KM, Kim JJ, Kim S, Park CK.

APMIS. 2007 Aug;115(8):982-6.

Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis

Lee EJ1¹, Park CK, Kim JW, Chang DK, Kim KM.

Histopathology. 2007 Jul;51(1):116-9. Epub 2007 May 31.

Localized gastric crystal-storing histiocytosis

Joo M¹, Kwak JE, Chang SH, Kim H, Chi JG, Moon YS, Kim KM.

Eur J Haematol. 2007 Jul;79(1):86-7. Epub 2007 May 28.

Absence of CASP7 and CASP8 mutation in gastrointestinal lymphomas

Yoo NJ¹, Soung YH, Lee SH, Kim KM, Lee SH.

J Pediatr Hematol Oncol. 2007 Jun;29(6):412-5.

Aggressive systemic mastocytosis after germ cell tumor of the ovary - C-KIT mutation documentation in both disease states

Lee JW1¹, Yang WS, Chung SY, Kang JH, Cho B, Kim HK, Kim KM, Jeong DC.

APMIS. 2007 Jun;115(6):713-8.

AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas

Cho EY1¹, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.

J Korean Med Sci. 2007 Feb;22(1):63-9.

Helicobacter heilmannii-associated gastritis: Clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis

Joo M1¹, Kwak JE, Chang SH, Kim H, Chi JG, Kim KA, Yang JH, Lee JS, Moon YS, Kim KM.

Am J Surg Pathol. 2007 Feb;31(2):224-32.

Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients

Kang DY1¹, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.

Breast Cancer Res Treat. 2006 Aug;98(3):337-42. Epub 2006 Feb 24.

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer

Park K1¹, Han S, Gwak GH, Kim HJ, Kim J, Kim KM.